Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Am J Med Genet A ; 170A(5): 1236-41, 2016 May.
Artigo em Inglês | MEDLINE | ID: mdl-26804344

RESUMO

Crisponi/CISS1 syndrome (MIM#272430) is a rare autosomal recessive disease characterized by major feeding difficulties, camptodactyly, and anhidrosis in early childhood; and the subsequent development of paradoxical cold-induced sweating and scoliosis later in life. The syndrome is caused by biallelic mutations in CRLF1 or, much less commonly, CLCF1. Although genotype/phenotype correlation has been elusive, it has been suggested that the level of the mutant protein may correlate with the phenotypic severity. However, we show in this series of 12 patients from four families, all previously unpublished, that the homogeneity of the recently described c.983dupG (p.Ser328Argfs∗2) mutation in CRLF1 was associated with a highly variable degree of severity, and that the phenotype significantly overlaps with the recently described COG6-related anhidrosis syndrome (MIM#615328). Another fifth previously unpublished family is also described with a novel mutation in CRLF1, c.605delC (p.Ala202Valfs*32). In Saudi Arabia the prevalence of the syndrome is probably underestimated due to the difficulty in making the diagnosis considering the complex phenotype with typical neonatal and evolutive features.


Assuntos
Deformidades Congênitas da Mão/genética , Hiperidrose/genética , Hipo-Hidrose/genética , Receptores de Citocinas/genética , Trismo/congênito , Proteínas Adaptadoras de Transporte Vesicular/genética , Adolescente , Adulto , Criança , Pré-Escolar , Citocinas/genética , Morte Súbita , Fácies , Feminino , Estudos de Associação Genética , Deformidades Congênitas da Mão/fisiopatologia , Humanos , Hiperidrose/fisiopatologia , Hipo-Hidrose/fisiopatologia , Masculino , Mutação , Linhagem , Trismo/genética , Trismo/fisiopatologia
2.
Birth Defects Res A Clin Mol Teratol ; 103(2): 100-4, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25363692

RESUMO

BACKGROUND: The role of consanguinity in the etiology of structural birth defects outside of chromosomal and inherited disorders has always been debated. We studied the independent role of consanguinity on birth defects in Saudi women with a high prevalence of consanguineous marriages. METHODS: This case and control study was nested within a 3-year prospective cohort study to examine patterns of fetal and neonatal malformations in Saudi women at Prince Sultan Military Medical City (PSMMC), Riyadh -Saudi Arabia. Consanguineous marriages were defined as marriages with first or second cousins (related); unions beyond second cousins (distant relatives) were considered unrelated for this study. RESULTS: During the 3-year study (July 2010 through June 2013), there were 28,646 total births; of these, we included 1,179 babies with major birth defects, and 1,262 babies as their controls. The consanguinity prevalence for all included women was 49.6%. The consanguinity among babies with major Birth Defects (BDs) was 54.5% and 45.2% for controls (P < 0.0002). The prevalence of major birth defects was 41.1 per 1000 total births. Univariate analysis showed that consanguinity had a statistically significant contribution in babies born with genetic syndromes, isolated renal defects, and isolated other defects (P < 0.05). Multivariate logistic regression analyses showed that consanguinity was an independent risk factor for this high prevalence of birth defects in the study population (P < 0.0002). CONCLUSION: The prevalence of major birth defects in the study population is higher than what is reported from European countries. Consanguinity is a significant independent risk factor for the high prevalence of birth defects.


Assuntos
Anormalidades Múltiplas/epidemiologia , Consanguinidade , Cardiopatias Congênitas/epidemiologia , Defeitos do Tubo Neural/epidemiologia , Anormalidades Urogenitais/epidemiologia , Anormalidades Múltiplas/patologia , Adulto , Estudos de Casos e Controles , Feminino , Cardiopatias Congênitas/patologia , Humanos , Lactente , Recém-Nascido , Modelos Logísticos , Masculino , Defeitos do Tubo Neural/patologia , Prevalência , Fatores de Risco , Arábia Saudita/epidemiologia , Anormalidades Urogenitais/patologia
3.
BMJ Open ; 9(9): e026351, 2019 09 05.
Artigo em Inglês | MEDLINE | ID: mdl-31492776

RESUMO

OBJECTIVE: To assess the three key issues for congenital anomalies (CAs) prevention and care, namely, CA prevalence, risk factor prevalence and survival, in a longitudinal cohort in Riyadh, Saudi Arabia. SETTING: Tertiary care centre, Riyadh, Saudi Arabia. PARTICIPANTS: Saudi women enrolled during pregnancy over 3 years and their 28 646 eligible pregnancy outcomes (births, stillbirths and elective terminations of pregnancy for foetal anomalies). The nested case-control study evaluated the CA risk factor profile of the underlying cohort. All CA cases (1179) and unaffected controls (1262) were followed through age 2 years. Referred mothers because of foetal anomaly and mothers who delivered outside the study centre and their pregnancy outcome were excluded. PRIMARY OUTCOME MEASURES: Prevalence and pattern of major CAs, frequency of CA-related risk factors and survival through age 2 years. RESULTS: The birth prevalence of CAs was 412/10 000 births (95% CI 388.6 to 434.9), driven mainly by congenital heart disease (148 per 10 000) (95% CI 134 to 162), renal malformations (113, 95% CI 110 to 125), neural tube defects (19, 95% CI 25.3 to 38.3) and chromosomal anomalies (27, 95% CI 21 to 33). In this study, the burden of potentially modifiable risk factors included high rates of diabetes (7.3%, OR 1.98, 95% CI 1.04 to 2.12), maternal age >40 years (7.0%, OR 2.1, 95% CI 1.35 to 3.3), consanguinity (54.5%, OR 1.5, 95% CI 1.28 to 1.81). The mortality for live births with CAs at 2 years of age was 15.8%. CONCLUSIONS: This study documented specific opportunities to improve primary prevention and care. Specifically, folic acid fortification (the neural tube defect prevalence was >3 times that theoretically achievable by optimal fortification), preconception diabetes screening and consanguinity-related counselling could have significant and broad health benefits in this cohort and arguably in the larger Saudi population.


Assuntos
Anormalidades Congênitas/epidemiologia , Estudos de Casos e Controles , Estudos de Coortes , Feminino , Cardiopatias Congênitas/epidemiologia , Humanos , Recém-Nascido , Modelos Logísticos , Idade Materna , Defeitos do Tubo Neural/epidemiologia , Defeitos do Tubo Neural/prevenção & controle , Gravidez , Resultado da Gravidez/epidemiologia , Prevalência , Prevenção Primária , Fatores de Risco , Arábia Saudita/epidemiologia
4.
Saudi Med J ; 29(6): 879-83, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18521470

RESUMO

OBJECTIVE: To describe and monitor the causes of neonatal and postneonatal deaths in the Neonatal Intensive Care Unit (NICU) over a 10-year-period. METHODS: This is a descriptive study of all infants who died in the NICU from January 1995 until December 2004 at Riyadh Military Hospital, Riyadh, Kingdom of Saudi Arabia. Data were collected prospectively on all infants admitted to NICU. The cause of death for each infant was discussed and determined by at least 2 consultant neonatologists. Deaths were classified according to the modified Wigglesworth's classification of perinatal death. RESULTS: During the study period, there were 79871 live births and 526 deaths, in which 446 (84.2%) were inborn deaths and 80 (15.8%) were outborn. Of the inborn deaths, 251 infants died between 1-6 days, 103 died between 7-27 days, and 92 died after 27 days. Lethal malformations led to death in 36%, prematurity and its complications in 42%, hypoxic ischemic encephalopathy in 5%, while other specific diagnoses, combined, led to death in 17% of the cases. CONCLUSION: Prematurity and its complications followed by congenital malformations were the leading causes of death.


Assuntos
Mortalidade Infantil/tendências , Causas de Morte , Humanos , Lactente , Recém-Nascido , Doenças do Prematuro/mortalidade , Estudos Prospectivos , Arábia Saudita/epidemiologia
5.
Prev Med Rep ; 2: 572-6, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26844119

RESUMO

BACKGROUND: Although the role of folic acid (FA) in preventing neural tube defects (NTDs) is well documented, its optimal intake in pregnant women is still low in many countries. Here, we prospectively studied the prevalence of NTDs in the newborns and the patterns of FA intake in pregnant Saudi mothers. METHODS: This case-control study was nested within a 3-year project (July 2010 to June 2013) to study the patterns of birth defects in the offspring of Saudi women who received their antenatal care and delivered at Prince Sultan Military Medical City, Riyadh-Saudi Arabia. Enrolled mothers were divided into 4 groups: group 1 (FA taken before pregnancy and continued regularly after conception), group 2 (FA taken post-conception), group 3 (no FA intake), and group 4 (did not remember or were unsure of taking FA). Control mothers were randomly selected from those with normal first obstetrical ultrasound scan at 18-22 weeks of gestation. RESULTS: The cohort included 30,531 mothers giving birth to 28,646 infants. We studied 1179 mothers of babies with birth defects (BDs) and 1262 control mothers. There were 237 (9.7%) mothers in-group 1; 2001 (82%) in-group 2; 154 (6.3%) in-group 3; and 49 (2%) in-group 4. There were 49 babies with NTDs, a prevalence of 1.7/1000 total births. Among the studied mothers 2274 (93%) took FA either full or partial course. CONCLUSION: The high prevalence of NTDs and the low optimal FA intake highlight the need for a strict implementation of staple food fortification and health education program for Saudi women.

6.
J Perinatol ; 22(6): 499-501, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12168130

RESUMO

Neonatal tracheal injury/perforation is an uncommon complication of traumatic deliveries or endotracheal intubation. We present a case of neonatal tracheal injury following delivery at term that presented with subcutaneous emphysema and pneumomediastinum before any attempt at intubation. The clinical course, treatment, and outcome are described.


Assuntos
Enfisema Mediastínico/diagnóstico , Enfisema Subcutâneo/diagnóstico , Traqueia/lesões , Doenças da Traqueia/diagnóstico , Traumatismos do Nascimento/complicações , Broncoscopia , Terapia Combinada , Diagnóstico Diferencial , Humanos , Recém-Nascido , Laringoscopia , Enfisema Mediastínico/etiologia , Enfisema Mediastínico/terapia , Prognóstico , Respiração Artificial/métodos , Medição de Risco , Enfisema Subcutâneo/etiologia , Enfisema Subcutâneo/terapia , Doenças da Traqueia/etiologia , Traqueotomia/métodos
8.
Curr Opin Pediatr ; 14(2): 151-6, 2002 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11981283

RESUMO

Despite the lack of evidence for its effectiveness in the treatment of acid-base disturbances in critically ill patients of all ages, and despite several lines of evidence that indicate it might be dangerous, bicarbonate therapy is used routinely in many neonatal intensive care units. The justification for the persistent use of this controversial therapy comes from a variety of sources, many based more in philosophy than in science. Clinicians contemplating the use of bicarbonate therapy should consider what they expect the intervention to accomplish and what evidence exists that their therapeutic objective will be met. Without rigorous scientific support for this therapy, it should be considered of unproven value and, therefore, experimental.


Assuntos
Acidose Láctica/tratamento farmacológico , Acidose Respiratória/tratamento farmacológico , Reanimação Cardiopulmonar/métodos , Síndrome do Desconforto Respiratório do Recém-Nascido/tratamento farmacológico , Bicarbonato de Sódio/uso terapêutico , Doença Aguda , Competência Clínica , Medicina Baseada em Evidências , Humanos , Recém-Nascido , Unidades de Terapia Intensiva Neonatal , Bicarbonato de Sódio/administração & dosagem , Bicarbonato de Sódio/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA